REMS@FDA has been updated with the following new or updated information.
- Extended-release and long-acting (ER/LA) opioid analgesics shared system REMS-specific page (updated on June 26, 2015). The changes are to the ER/LA Opioid Analgesics REMS Blueprint for Prescriber Education to incorporate:
- Product-specific information for a recently approved ER/LA opioid analgesic, Hysingla ER (hydrocodone bitartrate extended-release) tablets
- Newly approved intermediate strengths of fentanyl transdermal systems
- Revised titration information for Dolophine (methadone HCl tablets).